Anti-LASV glycoprotein complex [M30], Human IgG1, Fc Silent™, kappa

Catalogue Number: AB05116-10.3-BT-ABA

Manufacturer:Vector Laboratories, Inc (ABA)
Type:Recombinant Monoclonal
Alias:Lassa virus glycoprotein complex; GPC; Pre-glycoprotein polyprotein GP complex; Pre-GP-C; Stable signal peptide; SSP; Glycoprotein G1; GP1; Glycoprotein G2; GP2; 18.5C/R59ins-L108R; 18.5C-M30
Shipping Condition:Blue Ice
Unit(s): 1 mg
Host name: Human
Clone: M30
Isotype: IgG1
Immunogen: The original antibody was generated by introducing two mutations (R54 insertion and L100R) into the sequence of the parent clone 18.5C (an isolate from a human survivor of Lassa fever).
Application: ELISA, EM, NT, InVitroA

Additional Text

Purification

Purified

UniProt ID

P08669

Antibody Clonality

Recombinant Monoclonal

Storage Note

Store at 4⁰C for up to 3 months. Note, this antibody is provided without added preservatives, it is therefore recommed this antibody be handled under sterile conditions. For longer storage, aliquot and store at -20⁰C.

Gene ID

956585

Gene Name

LASVsSgp2

Short Description

This is a reformatted human IgG1 Fc Silent Fc Silent™ antibody, based on the original human IgG1 format, created for improved compatibility with existing reagents, assays and techniques.

Application Notes

The original antibody (human IgG1) was generated and shown to completely neutralize 100% of rVSV-LASV-LI particles with an IC50 of 2-4 nM. It also completely neutralized authentic LASV-LI in a Plaque-Reduction Neutralization Test (PRNT) (Hastie et al., 2019; PMID: 31398326). BLI characterization revealed high binding affinity, with apparent KD values of 0.559 nM, 0.494 nM, 0.154 nM, and 47.0 pM for LASV lineage I (LI) GP, LI-R198S-GP, LI-Q397H-GP, and LASV lineage IV (LIV) GP, respectively (Buck et al., 2022; PMID: 35730904).